↓ Skip to main content

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos

Overview of attention for article published in Malaria Journal, June 2012
Altmetric Badge

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
Published in
Malaria Journal, June 2012
DOI 10.1186/1475-2875-11-184
Pubmed ID
Authors

Mayfong Mayxay, Maniphone Khanthavong, Odai Chanthongthip, Mallika Imwong, Tiengkham Pongvongsa, Bouasy Hongvanthong, Samalane Phompida, Viengxay Vanisaveth, Nicholas J White, Paul N Newton

Abstract

The Lao Government changed the national policy for uncomplicated Plasmodium falciparum malaria from chloroquine to artemether-lumefantrine (AL) in 2005. Since then, no information on AL efficacy has been reported. With evidence of resistance to artemisinin derivatives in adjacent Cambodia, there has been a concern as to AL efficacy. Monitoring of AL efficacy would help the Lao Government to make decisions on appropriate malaria treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
Indonesia 1 1%
Burkina Faso 1 1%
Belgium 1 1%
Unknown 66 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 23%
Researcher 12 17%
Student > Ph. D. Student 7 10%
Student > Bachelor 5 7%
Other 4 6%
Other 12 17%
Unknown 15 21%
Readers by discipline Count As %
Medicine and Dentistry 29 41%
Nursing and Health Professions 6 8%
Agricultural and Biological Sciences 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Linguistics 1 1%
Other 12 17%
Unknown 17 24%